Curcumin as a Potential Treatment for COVID-19

Area of Science:

• * Pharmacology
• * Virology
• * Immunology

Background:

• * Coronavirus disease 2019 (COVID-19) presents significant management challenges due to its rapid global spread and high mortality.
• * Existing treatment strategies like drug repositioning lack specificity for SARS-CoV-2, the virus causing COVID-19.
• * The heterogeneous pathophysiology of COVID-19 and SARS-CoV-2's host modulation mechanisms require multifaceted therapeutic approaches.

Purpose of the Study:

• * To review the potential of curcumin as an adjuvant therapy for COVID-19.
• * To elucidate the specific mechanisms by which curcumin may interfere with SARS-CoV-2 infection.
• * To highlight curcumin's potential contribution to managing COVID-19.

Main Methods:

• * Literature review focusing on curcumin's pharmacological properties.
• * Analysis of curcumin's known effects on viral infections and inflammatory pathways.
• * Examination of curcumin's potential interactions with SARS-CoV-2 at various stages of infection.

Main Results:

• * Curcumin exhibits multiple beneficial properties including antiviral, anti-inflammatory, anticoagulant, antiplatelet, and cytoprotective effects.
• * These properties suggest curcumin can target various aspects of COVID-19 pathogenesis.
• * Curcumin's broad action potential makes it a promising candidate for integrated therapeutic strategies.

Conclusions:

• * Curcumin demonstrates significant potential as an adjuvant therapy for COVID-19.
• * Its diverse mechanisms of action can address the complex and multifactorial nature of the disease.
• * Further research into curcumin's role in COVID-19 treatment is warranted.